Advertisement

Time-based clinical and functional achievements in real-life HF patients on ARNI treatment

  • Cesare de Gregorio
    Correspondence
    Corresponding author.
    Affiliations
    Cardiology HF Outpatient Unit, Department of Clinical and Experimental Medicine, Postgraduate Residency School in Cardiovascular Diseases, G. Martino University Hospital, Messina, Italy

    Cardiology Unit at Department of Emergency, G. Martino University Hospital, Messina, Italy
    Search for articles by this author
  • Giulia Laterra
    Affiliations
    Cardiology HF Outpatient Unit, Department of Clinical and Experimental Medicine, Postgraduate Residency School in Cardiovascular Diseases, G. Martino University Hospital, Messina, Italy
    Search for articles by this author
  • Vittoria Vaccaro
    Affiliations
    Cardiology HF Outpatient Unit, Department of Clinical and Experimental Medicine, Postgraduate Residency School in Cardiovascular Diseases, G. Martino University Hospital, Messina, Italy
    Search for articles by this author
  • Roberto Bitto
    Affiliations
    Cardiology Unit at Department of Emergency, G. Martino University Hospital, Messina, Italy
    Search for articles by this author
  • Giuseppe Dattilo
    Affiliations
    Cardiology HF Outpatient Unit, Department of Clinical and Experimental Medicine, Postgraduate Residency School in Cardiovascular Diseases, G. Martino University Hospital, Messina, Italy

    Cardiology Unit at Department of Emergency, G. Martino University Hospital, Messina, Italy
    Search for articles by this author
Published:February 20, 2020DOI:https://doi.org/10.1016/j.ejim.2020.02.007
      The prevalence of chronic heart failure (CHF) in the general population is gradually increasing mainly due to prolonged life expectancy of the general population and effective interventional and medical treatment of acute cardiac syndromes. Even though in-hospital survival has improved, the evolution towards CHF is documented approximately in 5% of patients with recent acute syndromes, rising up to 10% when considering elderly people [
      • Camplain R.
      • Kucharska-Newton A.
      • Keyserling T.C.
      • Layton J.B.
      • Loehr L.
      • Heiss G
      Incidence of heart failure observed in emergency departments, ambulatory clinics, and hospitals.
      ,
      • Jones N.R.
      • Roalfe A.K.
      • Adoki I.
      • Hobbs F.D.R.
      • Taylor C.J
      Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis.
      ,
      • Scrutinio D.
      • Passantino A.
      • Guida P.
      • Ammirati E.
      • Oliva F.
      • Sarzi Braga S.
      • et al.
      Prognostic impact of comorbidities in hospitalized patients with acute exacerbation of chronic heart failure.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Camplain R.
        • Kucharska-Newton A.
        • Keyserling T.C.
        • Layton J.B.
        • Loehr L.
        • Heiss G
        Incidence of heart failure observed in emergency departments, ambulatory clinics, and hospitals.
        Am J Cardiol. 2018; 11: 1328-1335https://doi.org/10.1016/j.amjcard.2018.02.014
        • Jones N.R.
        • Roalfe A.K.
        • Adoki I.
        • Hobbs F.D.R.
        • Taylor C.J
        Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis.
        Eur J Heart Fail. 2019; 21: 1306-1325https://doi.org/10.1002/ejhf.1594
        • Scrutinio D.
        • Passantino A.
        • Guida P.
        • Ammirati E.
        • Oliva F.
        • Sarzi Braga S.
        • et al.
        Prognostic impact of comorbidities in hospitalized patients with acute exacerbation of chronic heart failure.
        Eur J Intern Med. 2016; 34: 63-67https://doi.org/10.1016/j.ejim.2018.11.002
        • Tsutamoto T.
        • Kanamori T.
        • Morigami N.
        • Sugimoto Y.
        • Yamaoka O.
        • Kinoshita M
        Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure.
        Circulation. 1993; 87: 70-75https://doi.org/10.1161/01.cir.87.1.70
        • McMurray J.J.
        • Packer M.
        • Desai A.S.
        • Gong J.
        • Lefkowitz M.P.
        • Rizkala A.R.
        • et al.
        PARADIGM-HF investigators and committees. angiotensin-neprilysin inhibition versus enalapril in heart failure.
        N Engl J Med. 2014; 371: 993-1004https://doi.org/10.1056/NEJMoa1409077
        • Arrigo M.
        • Vodovar N.
        • Nougué H.
        • Sadoune M.
        • Pemberton C.J.
        • Ballan P.
        • et al.
        The heart regulates the endocrine response to heart failure: cardiac contribution to circulating neprilysin.
        Eur Heart J. 2018; 39: 1794-1798https://doi.org/10.1093/eurheartj/ehx679
        • Morrow D.A.
        • Velazquez E.J.
        • DeVore A.D.
        • Desai A.S.
        • Duffy C.I.
        • Ambrosy A.P.
        • Gurmu Y.
        • et al.
        Clinical outcomes in patients with acute decompensated heart failure randomly assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF trial.
        Circulation. 2019; 139: 2285-2288https://doi.org/10.1161/CIRCULATIONAHA.118.039331
        • Vitale G.
        • Romano G.
        • Di Franco A.
        • Caccamo G.
        • Nugara C.
        • Ajello L.
        • et al.
        Early effects of Sacubitril/Valsartan on exercise tolerance in patients with heart failure with reduced ejection fraction.
        J Clin Med. 2019; 8 (pii): E262https://doi.org/10.3390/jcm8020262
        • Voigt J.U.
        • Cvijic M.
        2- and 3-Dimensional myocardial strain in cardiac health and disease.
        JACC Cardiovasc Imaging. 2019; 12: 1849-1863https://doi.org/10.1016/j.jcmg.2019.01.044
        • Beltrán P.
        • Palau P.
        • Domínguez E.
        • Faraudo M.
        • Núñez E.
        • Guri O.
        • et al.
        Sacubitril/valsartan and short-term changes in the 6-minute walk test: a pilot study.
        Int J Cardiol. 2018; 252: 136-139https://doi.org/10.1016/j.ijcard.2017.10.074